| # | Drug | Count |
|---|---|---|
| 0 | LATANOPROST | 29 |
| 1 | BIMATOPROST | 25 |
| 2 | TRAVOPROST | 10 |
| 3 | LEVOTHYROXINE SODIUM | 7 |
| 4 | PANITUMUMAB | 7 |
| 5 | ATENOLOL | 5 |
| 6 | BRINZOLAMIDE/BRIMONIDINE TARTRATE | 4 |
| 7 | OXALIPLATIN | 4 |
| 8 | ASPIRIN | 3 |
| 9 | ASPIRIN 325 MG | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | LATANOPROST OPHTHALMIC SOLUTION 0.005% | 3 | 0.0047 |
| 1 | PRAZIQUANTEL | 1 | 0.0033 |
| 2 | POLYETHYLENE GLYCOL 400 AND PROPYLENE GLYCOL | 2 | 0.0018 |
| 3 | SODIUM HYALURONATE | 1 | 0.0012 |
| 4 | TRAVOPROST | 10 | 0.0012 |
| 5 | BRINZOLAMIDE/BRIMONIDINE TARTRATE | 4 | 0.0010 |
| 6 | BIMATOPROST | 25 | 0.0009 |
| 7 | TAFLUPROST | 2 | 0.0007 |
| 8 | LATANOPROST | 29 | 0.0006 |
| 9 | DHEA (DEHYDROEPIANDROSTERONE) | 1 | 0.0005 |
| # | Drug class | Count |
|---|---|---|
| 0 | Prostaglandin Analog [EPC] | 68 |
| 1 | Carbonic Anhydrase Inhibitor [EPC] | 7 |
| 2 | Epidermal Growth Factor Receptor Antagonist [EPC] | 7 |
| 3 | beta-Adrenergic Blocker [EPC] | 6 |
| 4 | Platinum-based Drug [EPC] | 4 |
| 5 | Vitamin B12 [EPC] | 4 |
| 6 | Vitamin C [EPC] | 4 |
| 7 | Vitamin D [EPC] | 4 |
| 8 | Kinase Inhibitor [EPC] | 3 |
| 9 | Nonsteroidal Anti-inflammatory Drug [EPC] | 3 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Prostaglandin Analog [EPC] | 68 | 0.0007 |
| 1 | Semifluorinated Alkane [EPC] | 1 | 0.0004 |
| 2 | Carbonic Anhydrase Inhibitor [EPC] | 7 | 0.0003 |
| 3 | Anthelmintic [EPC] | 1 | 0.0003 |
| 4 | Photoenhancer [EPC] | 1 | 0.0003 |
| 5 | Epidermal Growth Factor Receptor Antagonist [EPC] | 7 | 0.0001 |
| 6 | Lymphocyte Function-Associated Antigen-1 Antagonist [EPC] | 1 | 0.0001 |
| 7 | Prostaglandin E1 Analog [EPC] | 1 | 0.0001 |
| 8 | Folate Analog [EPC] | 2 | 0.0000 |
| 9 | Vitamin A [EPC] | 2 | 0.0000 |